GGrantIndex
← Leaderboards

Karolinska Institute

Stockholm

Compare ↔
$40,821,187
Total funding
53
Grants

Funding over time

peak $4.4M · FY2005–25
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$38,730,053 · 51
ATSDR$2,091,134 · 2

By mechanism

R01$30,534,908 · 25
U01$4,469,723 · 2
R21$1,881,699 · 8
RF1$1,562,430 · 1
F32$820,339 · 6
R56$542,614 · 2

Investigators at Karolinska Institute

Investigator-initiatedAll funding

InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).

Rising Stars

First grant in the last 5 yrs

1Liselotte Vogdrup Petersen$198,5721 gr2Lisa Dinkler$198,5721 gr3Lu Yi$198,5721 gr

Emerging Leaders

6–10 yrs in

1Sara Hagg$2,535,5802 gr2Fang Fang$2,091,1342 gr3Ivan Nalvarte$1,754,7471 gr4Sarah E Bergen$1,464,3212 gr

All-Time

Most funded here, all years

1Tatiana G Deliagina$3,752,0202 gr2Sara Hagg$2,535,5802 gr3Per Hall$2,122,6971 gr4Fang Fang$2,091,1342 gr5Gunnar Steineck$1,977,1021 gr6Ivan Nalvarte$1,754,7471 gr7Robb W Glenny$1,752,2142 gr8Ole Kiehn$1,523,2592 gr

Largest grants

Repurposing drugs for Alzheimer´s disease using a reverse translational approach$1,562,430
RF1 · FY2021 · AG
Interstitial Cystitis in Swedish Twins$1,007,858
U01 · FY2005 · DK
Interstitial Cystitis in Swedish Twins$935,908
U01 · FY2006 · DK
3/3 Eating Disorders Genetics Initiative 2 (EDGI2)$539,816
R01 · FY2024 · MH
T CRUZI GENOME: UU$539,700
U01 · FY2002 · AI
T CRUZI GENOME: UU$535,999
U01 · FY2003 · AI
T CRUZI GENOME: UU$535,226
U01 · FY2004 · AI
Drug targeting the dynamics of opioid systems in alcohol dependence$523,188
R01 · FY2020 · AA
Drug targeting the dynamics of opioid systems in alcohol dependence$519,188
R01 · FY2023 · AA
Drug targeting the dynamics of opioid systems in alcohol dependence$519,188
R01 · FY2024 · AA
Drug targeting the dynamics of opioid systems in alcohol dependence$519,188
R01 · FY2022 · AA
Drug targeting the dynamics of opioid systems in alcohol dependence$519,188
R01 · FY2021 · AA
Identify and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis - A Unique Contribution from Sweden$499,560
R01 · FY2021 · TS
Identify and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis - A Unique Contribution from Sweden$498,395
R01 · FY2022 · TS
Identify and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis - A Unique Contribution from Sweden$493,735
R01 · FY2023 · TS
Repurposing drugs for Alzheimer´s disease using a reverse translational approach$488,631
R01 · FY2024 · AG
Repurposing drugs for Alzheimer´s disease using a reverse translational approach$484,519
R01 · FY2025 · AG
Understanding the role of menopause and estrogen receptor activation for Alzheimer's disease risk$475,973
R01 · FY2020 · AG
Understanding the role of menopause and estrogen receptor activation for Alzheimer's disease risk$469,300
R01 · FY2021 · AG
NEUROANATOMY/REGENERATION RELATED TO SPINAL CORD INJURY$464,277
N01 · FY2000 · DA